NCT03085914 2022-09-23A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)Incyte CorporationPhase 1/2 Completed70 enrolled 17 charts
NCT01803282 2020-06-02Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid TumorsGilead SciencesPhase 1 Completed236 enrolled 21 charts